Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 111 In -pentetreotide
2. 111-indium-pentetreotide
3. In-111 Pentetreotide
4. Indium Ln-111 Pentetreotide
5. Indium-pentetreotide
6. Octreoscan
7. Octreoscan 111
8. Pentetreotide
1. 159201-00-0
2. Indium In 111 Pentetreotide [usan]
3. 2-[2-[[2-[[1-[[10-(4-aminobutyl)-16-benzyl-4-(1,3-dihydroxybutan-2-ylcarbamoyl)-7-(1-hydroxyethyl)-13-(1h-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicos-19-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-2-oxoethyl]-(carboxylatomethyl)amino]ethyl-[2-[bis(carboxylatomethyl)amino]ethyl]amino]acetate;hydron;indium(3+)
4. Octreoscan (tn)
5. Indium In 111 Pentetreotide (usp)
6. Indate(1-), (n-(2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)ethyl)-n-(carboxymethyl)glycyl-d-phenylalanyl-l-cysteinyl-l-phenylalanyl-d-tryptophyl-l-lysyl-l-threonyl-n-(2-hydroxy-1-(hydroxymethyl)propyl)-l-cysteinamide Cyclic (3-8)-disulfidato(4-))-, Hydrogen, (r-(r*,r*))-
7. 139096-04-1
8. D02108
Molecular Weight | 1506.4 g/mol |
---|---|
Molecular Formula | C63H84InN13O19S2 |
Hydrogen Bond Donor Count | 14 |
Hydrogen Bond Acceptor Count | 25 |
Rotatable Bond Count | 30 |
Exact Mass | 1505.4486636 g/mol |
Monoisotopic Mass | 1505.4486636 g/mol |
Topological Polar Surface Area | 556 Ų |
Heavy Atom Count | 98 |
Formal Charge | 0 |
Complexity | 2570 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 10 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Octreoscan |
PubMed Health | Indium In 111 Pentetreotide (Injection) |
Drug Classes | Diagnostic Agent, Radiopharmaceutical Imaging |
Active Ingredient | Indium in-111 pentetreotide kit |
Dosage Form | Injectable |
Route | Injection |
Strength | 3mci/ml |
Market Status | Prescription |
Company | Mallinckrodt |
2 of 2 | |
---|---|
Drug Name | Octreoscan |
PubMed Health | Indium In 111 Pentetreotide (Injection) |
Drug Classes | Diagnostic Agent, Radiopharmaceutical Imaging |
Active Ingredient | Indium in-111 pentetreotide kit |
Dosage Form | Injectable |
Route | Injection |
Strength | 3mci/ml |
Market Status | Prescription |
Company | Mallinckrodt |
ABOUT THIS PAGE
61
PharmaCompass offers a list of Octreoscan API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Octreoscan manufacturer or Octreoscan supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Octreoscan manufacturer or Octreoscan supplier.
PharmaCompass also assists you with knowing the Octreoscan API Price utilized in the formulation of products. Octreoscan API Price is not always fixed or binding as the Octreoscan Price is obtained through a variety of data sources. The Octreoscan Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Octreoscan manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Octreoscan, including repackagers and relabelers. The FDA regulates Octreoscan manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Octreoscan API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Octreoscan supplier is an individual or a company that provides Octreoscan active pharmaceutical ingredient (API) or Octreoscan finished formulations upon request. The Octreoscan suppliers may include Octreoscan API manufacturers, exporters, distributors and traders.
click here to find a list of Octreoscan suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Octreoscan DMF (Drug Master File) is a document detailing the whole manufacturing process of Octreoscan active pharmaceutical ingredient (API) in detail. Different forms of Octreoscan DMFs exist exist since differing nations have different regulations, such as Octreoscan USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Octreoscan DMF submitted to regulatory agencies in the US is known as a USDMF. Octreoscan USDMF includes data on Octreoscan's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Octreoscan USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Octreoscan suppliers with USDMF on PharmaCompass.
Octreoscan Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Octreoscan GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Octreoscan GMP manufacturer or Octreoscan GMP API supplier for your needs.
A Octreoscan CoA (Certificate of Analysis) is a formal document that attests to Octreoscan's compliance with Octreoscan specifications and serves as a tool for batch-level quality control.
Octreoscan CoA mostly includes findings from lab analyses of a specific batch. For each Octreoscan CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Octreoscan may be tested according to a variety of international standards, such as European Pharmacopoeia (Octreoscan EP), Octreoscan JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Octreoscan USP).